Whitehawk Therapeutics (WHWK)

• Market cap: $127M
• 1 day: 0.37%
• 5 days: 1.12%
• 1 month: 9.31%
• 3 months: 20%
• 6 months: 50.84%
• Year to date: 10.66%
• 1 year: -6.25%
• 5 years: -87.67%
• 10 years: -95.38%
• Sector: Healthcare
• Industry: Biotechnology

About: Whitehawk Therapeutics Inc is a preclinical stage oncology therapeutics. The company is engaged in applying technologies to established tumor biology to efficiently deliver improved cancer treatments. The company's three-asset ADC portfolio is engineered to overcome the limitations of first-generation predecessors to deliver a meaningful impact for patients with difficult-to-treat cancers.

Employees: 22